Kampanjeplan PepGen Inc.
Avansert tidsplan
Enkel graf
Om selskapet PepGen Inc.
PepGen Inc., биотехнологическая компания клинической стадии, занимается разработкой олигонуклеотидных терапевтических средств для лечения тяжелых нервно-мышечных и неврологических заболеваний. Ведущим продуктом компании-кандидата является PGN-EDO51, пептид EDO, проходящий фазу I клинических испытаний для лечения пациентов с мышечной дистрофией Дюшенна (МДД). Он также разрабатывает PGN-EDODM1, конъюгированный с пептидом EDO PMO для лечения миотонической дистрофии 1 типа, а также терапевтические кандидаты EDO, такие как PGN-EDO53, PGN-EDO45 и PGN-EDO44 для лечения МДД. flere detaljerIPO date | 2022-05-06 |
---|---|
ISIN | US7133171055 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.pepgen.com |
Цена ао | 1.53 |
Prisendring per dag: | 0% (1.53) |
---|---|
Prisendring per uke: | +6.25% (1.44) |
Prisendring per måned: | -22.34% (1.97) |
Prisendring over 3 måneder: | -70% (5.1) |
Prisendring over seks måneder: | -84.11% (9.63) |
Prisendring per år: | -90.97% (16.95) |
Prisendring over 3 år: | 0% (1.53) |
Prisendring over 5 år: | 0% (1.53) |
Prisendring over 10 år: | 0% (1.53) |
Prisendring siden begynnelsen av året: | -60.67% (3.89) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Institusjoner | Volum | Dele, % |
---|---|---|
RA Capital Management, L.P. | 8131952 | 25.13 |
Viking Global Investors, L.P. | 1482434 | 4.58 |
Adage Capital Partners GP L.L.C. | 1100000 | 3.4 |
Janus Henderson Group PLC | 988204 | 3.05 |
FMR, LLC | 738022 | 2.28 |
Blackrock Inc. | 723538 | 2.24 |
Laurion Capital Management, LP | 664516 | 2.05 |
Vanguard Group Inc | 506179 | 1.56 |
Suvretta Capital Management, LLC | 486611 | 1.5 |
Samsara BioCapital, LLC | 436813 | 1.35 |
ETF | Dele, % | Lønnsomhet for året, % | Utbytte, % |
---|---|---|---|
iShares Neuroscience and Healthcare ETF | 0.44149 | 19.72 | 0.03 |
Invesco Dorsey Wright SmallCap Momentum ETF | 0.20834 | 33.91 | 0.61241 |
iShares Micro-Cap ETF | 0.03667 | 17.09 | 1.54048 |
Avantis U.S Small Cap Equity ETF | 0.01592 | 27.77 | 1.68271 |
Vanguard Russell 2000 ETF | 0.01 | 17.16 | 1.48801 |
Vanguard Russell 2000 Growth ETF | 0.01 | 23.05 | 0.60264 |
![]() |
0.0092 | 38.04 | 0.6026 |
![]() |
0.00309 | 89.82 | 1.47873 |
ProShares Hedge Replication ETF | 0.00088 | 5.92 | 1.47892 |
iShares Russell 3000 ETF | 0.00046 | 24.83 | 1.43482 |
Dimensional US Core Equity Market ETF | 0.00037 | 30.98 | 1.40618 |
Avantis U.S. Equity ETF | 0.00018 | 23.04 | 1.59151 |
Dimensional U.S. Targeted Value ETF | 0.00017 | 26.01 | 1.93487 |
Dimensional U.S. Equity ETF | 0.00013 | 31.53 | 1.3557 |
Dimensional U.S. Core Equity 2 ETF | 0.00004 | 30.76 | 1.47098 |
Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Dr. James G. McArthur Ph.D. | President, CEO, Treasurer, Secretary & Director | 834.98k | 1962 (63 år) |
Dr. Michelle L. Mellion M.D. | Chief Medical Officer | N/A | 1976 (49 år) |
Mr. Niels Svenstrup Ph.D. | Senior Vice President of Chemistry, Manufacturing & Control | 455.15k | 1970 (55 år) |
Mr. Noel P. Donnelly M.B.A. | Chief Financial Officer | 650.17k | 1970 (55 år) |
Dr. Michael Gait Ph.D. | Founder & Scientific Advisory Board Member | N/A | |
Ms. Emiko Bryant | Chief of Staff | N/A | |
Mr. David E. Borah C.F.A. | Senior VP of IR & Corporate Communications | ||
Ms. Mary Beth DeLena J.D. | General Counsel & Secretary | 1968 (57 år) | |
Dr. Hayley Parker Ph.D. | Senior Vice President of Global Regulatory Affairs | ||
Dr. Afsaneh Mohebbi Ph.D. | Senior VP of Portfolio and Program Management |
Adresse: United States, Cambridge. MA, 245 Main Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.pepgen.com
Nettsted: https://www.pepgen.com